Kovack Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$144K Buy
+10,899
New +$114K 0.01% 1010
2026
Q1
– Sell
-46,023
Closed -$282K – 1014
2025
Q4
$282K Buy
+46,023
New +$497K 0.01% 777

Other funds holding ARCT

Kovack Advisors's ARCT Position: Q3 2026 in Review

Kovack Advisors opened a new position in Arcturus Therapeutics (ARCT) in Q3 2026: 10,899 shares worth $144K. The stake represents 0.01% of the portfolio and ranks #1010 among its holdings. This is a return to the name: Kovack Advisors previously reported a position in ARCT as recently as Q4 2025.

Kovack Advisors first reported a position in ARCT in Q4 2025 and has held it in 2 quarters since. The position peaked at $282K in Q4 2025. 155 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • Kovack Advisors held 10,899 shares of Arcturus Therapeutics worth $144K as of Q3 2026.
  • Arcturus Therapeutics was a new Kovack Advisors position in Q3 2026.
  • Arcturus Therapeutics made up 0.01% of Kovack Advisors's portfolio in Q3 2026, its #1010 holding.
  • Kovack Advisors first reported a position in Arcturus Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Kovack Advisors's Arcturus Therapeutics position peaked at $282K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on Kovack Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.